May 8, 2018 / 11:39 AM / in 7 months

BUZZ-Valeant Pharma: To rename itself as Bausch Health, raises revenue outlook

** Canadian drugmaker’s U.S.-listed shares rise 5.73 pct at $19.20 in premarket trade

** VRX is fourth most actively traded across all U.S. exchanges in premarket trade; VRX one of the biggest pct gainers among NYSE-listed stocks

** Co raised its 2018 revenue forecast, and said it would change its name to Bausch Health Companies Inc

** Co to change its name and roll out a new corporate brand identity in July 2018; to trade under new ticker “BHC”

** Up to Monday’s close, stock had fallen ~13 pct this year (Reporting by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below